Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small cell lung cancer.

CONCLUSION: exRNA-seq from a small amount (400-500 μl) of plasma opens new possibilities for exploring lung cancer biomarkers in the plasma.
PMID: 32526228 [PubMed - as supplied by publisher]

Source: Clinical Biochemistry - June 7, 2020 Category: Biochemistry Authors: Wang L, Wang J, Jia E, Liu Z, Ge Q, Zhao X Tags: Clin Biochem Source Type: research